APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hemoglobinopathy Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Hemoglobinopathy Testing Services Market Analysis and Forecast 2026-2032

Report ID 173997490222 December 2025191 pages

Choose your research edition.

Industry ResearchHemoglobinopathy Testing Services Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemoglobinopathy Testing Services Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Hemoglobinopathy Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemoglobinopathy Testing Services Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemoglobinopathy Testing Services Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Hemoglobinopathy Testing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Hemoglobinopathy Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Hemoglobinopathy Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Hemoglobinopathy Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Hemoglobinopathy Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Hemoglobinopathy Testing Services include Novartis, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca, HemaQuest Pharmaceuticals, Emmaus Medical, Celgene Corporation, Bluebird Bio and Acceleron Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Hemoglobinopathy Testing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Hemoglobinopathy Testing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Hemoglobinopathy Testing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hemoglobinopathy Testing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Hemoglobinopathy Testing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Hemoglobinopathy Testing Services revenue, projected growth trends, production technology, application and end-user industry.

Hemoglobinopathy Testing Services Segment by Company

Novartis

Eli Lilly and Company

Bristol-Myers Squibb

AstraZeneca

HemaQuest Pharmaceuticals

Emmaus Medical

Celgene Corporation

Bluebird Bio

Acceleron Pharma

Hemoglobinopathy Testing Services Segment by Type

Hydroxyurea

Zynteglo

Luspatercept

Glutamine

Others

Hemoglobinopathy Testing Services Segment by Application

Sickle Cell Diseases

Thalassemia

Other

Hemoglobinopathy Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemoglobinopathy Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemoglobinopathy Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemoglobinopathy Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Hemoglobinopathy Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Hemoglobinopathy Testing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemoglobinopathy Testing Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hydroxyurea Major Player Table 3. Zynteglo Major Player Table 4. Luspatercept Major Player Table 5. Glutamine Major Player Table 6. Others Major Player Table 7. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Sickle Cell Diseases Major Player Table 9. Thalassemia Major Player Table 10. Other Major Player Table 11. Hemoglobinopathy Testing Services Industry Trends Table 12. Hemoglobinopathy Testing Services Industry Drivers Table 13. Hemoglobinopathy Testing Services Industry Opportunities and Challenges Table 14. Hemoglobinopathy Testing Services Industry Restraints Table 15. Global Hemoglobinopathy Testing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Hemoglobinopathy Testing Services Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Hemoglobinopathy Testing Services Market Share by Region (2021-2026) Table 18. Global Hemoglobinopathy Testing Services Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Hemoglobinopathy Testing Services Market Share by Region (2027-2032) Table 20. Global Hemoglobinopathy Testing Services Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Hemoglobinopathy Testing Services Revenue Market Share by Players (2021-2026) Table 22. Global Hemoglobinopathy Testing Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Hemoglobinopathy Testing Services Key Players Headquarters & Area Served Table 24. Global Hemoglobinopathy Testing Services Players, Product Type & Application Table 25. Global Hemoglobinopathy Testing Services Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Hemoglobinopathy Testing Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Hemoglobinopathy Testing Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Hemoglobinopathy Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Hemoglobinopathy Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2021-2026) Table 32. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2027-2032) Table 33. Global Hemoglobinopathy Testing Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Hemoglobinopathy Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Hemoglobinopathy Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2021-2026) Table 37. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2027-2032) Table 38. Novartis Company Information Table 39. Novartis Business Overview Table 40. Novartis Hemoglobinopathy Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Novartis Hemoglobinopathy Testing Services Product Portfolio Table 42. Novartis Recent Development Table 43. Eli Lilly and Company Company Information Table 44. Eli Lilly and Company Business Overview Table 45. Eli Lilly and Company Hemoglobinopathy Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Eli Lilly and Company Hemoglobinopathy Testing Services Product Portfolio Table 47. Eli Lilly and Company Recent Development Table 48. Bristol-Myers Squibb Company Information Table 49. Bristol-Myers Squibb Business Overview Table 50. Bristol-Myers Squibb Hemoglobinopathy Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Bristol-Myers Squibb Hemoglobinopathy Testing Services Product Portfolio Table 52. Bristol-Myers Squibb Recent Development Table 53. AstraZeneca Company Information Table 54. AstraZeneca Business Overview Table 55. AstraZeneca Hemoglobinopathy Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. AstraZeneca Hemoglobinopathy Testing Services Product Portfolio Table 57. AstraZeneca Recent Development Table 58. HemaQuest Pharmaceuticals Company Information Table 59. HemaQuest Pharmaceuticals Business Overview Table 60. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Product Portfolio Table 62. HemaQuest Pharmaceuticals Recent Development Table 63. Emmaus Medical Company Information Table 64. Emmaus Medical Business Overview Table 65. Emmaus Medical Hemoglobinopathy Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Emmaus Medical Hemoglobinopathy Testing Services Product Portfolio Table 67. Emmaus Medical Recent Development Table 68. Celgene Corporation Company Information Table 69. Celgene Corporation Business Overview Table 70. Celgene Corporation Hemoglobinopathy Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Celgene Corporation Hemoglobinopathy Testing Services Product Portfolio Table 72. Celgene Corporation Recent Development Table 73. Bluebird Bio Company Information Table 74. Bluebird Bio Business Overview Table 75. Bluebird Bio Hemoglobinopathy Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Bluebird Bio Hemoglobinopathy Testing Services Product Portfolio Table 77. Bluebird Bio Recent Development Table 78. Acceleron Pharma Company Information Table 79. Acceleron Pharma Business Overview Table 80. Acceleron Pharma Hemoglobinopathy Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Acceleron Pharma Hemoglobinopathy Testing Services Product Portfolio Table 82. Acceleron Pharma Recent Development Table 83. North America Hemoglobinopathy Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Hemoglobinopathy Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Hemoglobinopathy Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Hemoglobinopathy Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Hemoglobinopathy Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. North America Hemoglobinopathy Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 89. North America Hemoglobinopathy Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 90. Europe Hemoglobinopathy Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Hemoglobinopathy Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Hemoglobinopathy Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Hemoglobinopathy Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Hemoglobinopathy Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Europe Hemoglobinopathy Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Hemoglobinopathy Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 97. China Hemoglobinopathy Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 98. China Hemoglobinopathy Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 99. China Hemoglobinopathy Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 100. China Hemoglobinopathy Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 101. Asia Hemoglobinopathy Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 102. Asia Hemoglobinopathy Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 103. Asia Hemoglobinopathy Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 104. Asia Hemoglobinopathy Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Hemoglobinopathy Testing Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Asia Hemoglobinopathy Testing Services Revenue by Region (US$ Million) & (2021-2026) Table 107. Asia Hemoglobinopathy Testing Services Revenue by Region (US$ Million) & (2027-2032) Table 108. SAMEA Hemoglobinopathy Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 109. SAMEA Hemoglobinopathy Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 110. SAMEA Hemoglobinopathy Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 111. SAMEA Hemoglobinopathy Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 112. SAMEA Hemoglobinopathy Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. SAMEA Hemoglobinopathy Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 114. SAMEA Hemoglobinopathy Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Hemoglobinopathy Testing Services Image Figure 2. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemoglobinopathy Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hydroxyurea Image Figure 5. Zynteglo Image Figure 6. Luspatercept Image Figure 7. Glutamine Image Figure 8. Others Image Figure 9. Global Hemoglobinopathy Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Hemoglobinopathy Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 11. Sickle Cell Diseases Image Figure 12. Thalassemia Image Figure 13. Other Image Figure 14. Global Hemoglobinopathy Testing Services Market Size (US$ Million) & (2021-2032) Figure 15. Global Hemoglobinopathy Testing Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Hemoglobinopathy Testing Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Hemoglobinopathy Testing Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Hemoglobinopathy Testing Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Hemoglobinopathy Testing Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2021-2032) Figure 22. Global Hemoglobinopathy Testing Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2021-2032) Figure 25. North America Hemoglobinopathy Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032) Figure 27. North America Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032) Figure 28. North America Hemoglobinopathy Testing Services Revenue Share by Country (2021-2032) Figure 29. United States Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Hemoglobinopathy Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032) Figure 34. Europe Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032) Figure 35. Europe Hemoglobinopathy Testing Services Revenue Share by Country (2021-2032) Figure 36. Germany Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Hemoglobinopathy Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032) Figure 46. China Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032) Figure 47. Asia Hemoglobinopathy Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032) Figure 49. Asia Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032) Figure 50. Asia Hemoglobinopathy Testing Services Revenue Share by Region (2021-2032) Figure 51. Japan Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Hemoglobinopathy Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032) Figure 59. SAMEA Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032) Figure 60. SAMEA Hemoglobinopathy Testing Services Revenue Share by Country (2021-2032) Figure 61. Brazil Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Hemoglobinopathy Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Hydroxyurea
  • Zynteglo
  • Luspatercept
  • Glutamine
  • Others
Applications
  • Sickle Cell Diseases
  • Thalassemia
  • Other
Companies covered
  • Novartis
  • Eli Lilly and Company
  • Bristol-Myers Squibb
  • AstraZeneca
  • HemaQuest Pharmaceuticals
  • Emmaus Medical
  • Celgene Corporation
  • Bluebird Bio
  • Acceleron Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Hemoglobinopathy Testing Services Market by Type
  3. 1.2.1 Global Hemoglobinopathy Testing Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hydroxyurea
  5. 1.2.3 Zynteglo
  6. 1.2.4 Luspatercept
  7. 1.2.5 Glutamine
  8. 1.2.6 Others
  9. 1.3 Hemoglobinopathy Testing Services Market by Application
  10. 1.3.1 Global Hemoglobinopathy Testing Services Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Sickle Cell Diseases
  12. 1.3.3 Thalassemia
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Hemoglobinopathy Testing Services Market Dynamics
  1. 2.1 Hemoglobinopathy Testing Services Industry Trends
  2. 2.2 Hemoglobinopathy Testing Services Industry Drivers
  3. 2.3 Hemoglobinopathy Testing Services Industry Opportunities and Challenges
  4. 2.4 Hemoglobinopathy Testing Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Hemoglobinopathy Testing Services Market Perspective (2021-2032)
  2. 3.2 Global Hemoglobinopathy Testing Services Growth Trends by Region
  3. 3.2.1 Global Hemoglobinopathy Testing Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Hemoglobinopathy Testing Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Hemoglobinopathy Testing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Hemoglobinopathy Testing Services Revenue by Players
  2. 4.1.1 Global Hemoglobinopathy Testing Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Hemoglobinopathy Testing Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Hemoglobinopathy Testing Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Hemoglobinopathy Testing Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Hemoglobinopathy Testing Services Key Players Headquarters & Area Served
  7. 4.4 Global Hemoglobinopathy Testing Services Players, Product Type & Application
  8. 4.5 Global Hemoglobinopathy Testing Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Hemoglobinopathy Testing Services Market CR5 and HHI
  11. 4.6.3 2025 Hemoglobinopathy Testing Services Tier 1, Tier 2, and Tier 3
5 Hemoglobinopathy Testing Services Market Size by Type
  1. 5.1 Global Hemoglobinopathy Testing Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Hemoglobinopathy Testing Services Revenue by Type (2021-2032)
  3. 5.3 Global Hemoglobinopathy Testing Services Revenue Market Share by Type (2021-2032)
6 Hemoglobinopathy Testing Services Market Size by Application
  1. 6.1 Global Hemoglobinopathy Testing Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Hemoglobinopathy Testing Services Revenue by Application (2021-2032)
  3. 6.3 Global Hemoglobinopathy Testing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Hemoglobinopathy Testing Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Hemoglobinopathy Testing Services Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Eli Lilly and Company
  8. 7.2.1 Eli Lilly and Company Company Information
  9. 7.2.2 Eli Lilly and Company Business Overview
  10. 7.2.3 Eli Lilly and Company Hemoglobinopathy Testing Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Eli Lilly and Company Hemoglobinopathy Testing Services Product Portfolio
  12. 7.2.5 Eli Lilly and Company Recent Developments
  13. 7.3 Bristol-Myers Squibb
  14. 7.3.1 Bristol-Myers Squibb Company Information
  15. 7.3.2 Bristol-Myers Squibb Business Overview
  16. 7.3.3 Bristol-Myers Squibb Hemoglobinopathy Testing Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bristol-Myers Squibb Hemoglobinopathy Testing Services Product Portfolio
  18. 7.3.5 Bristol-Myers Squibb Recent Developments
  19. 7.4 AstraZeneca
  20. 7.4.1 AstraZeneca Company Information
  21. 7.4.2 AstraZeneca Business Overview
  22. 7.4.3 AstraZeneca Hemoglobinopathy Testing Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 AstraZeneca Hemoglobinopathy Testing Services Product Portfolio
  24. 7.4.5 AstraZeneca Recent Developments
  25. 7.5 HemaQuest Pharmaceuticals
  26. 7.5.1 HemaQuest Pharmaceuticals Company Information
  27. 7.5.2 HemaQuest Pharmaceuticals Business Overview
  28. 7.5.3 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 HemaQuest Pharmaceuticals Hemoglobinopathy Testing Services Product Portfolio
  30. 7.5.5 HemaQuest Pharmaceuticals Recent Developments
  31. 7.6 Emmaus Medical
  32. 7.6.1 Emmaus Medical Company Information
  33. 7.6.2 Emmaus Medical Business Overview
  34. 7.6.3 Emmaus Medical Hemoglobinopathy Testing Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Emmaus Medical Hemoglobinopathy Testing Services Product Portfolio
  36. 7.6.5 Emmaus Medical Recent Developments
  37. 7.7 Celgene Corporation
  38. 7.7.1 Celgene Corporation Company Information
  39. 7.7.2 Celgene Corporation Business Overview
  40. 7.7.3 Celgene Corporation Hemoglobinopathy Testing Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Celgene Corporation Hemoglobinopathy Testing Services Product Portfolio
  42. 7.7.5 Celgene Corporation Recent Developments
  43. 7.8 Bluebird Bio
  44. 7.8.1 Bluebird Bio Company Information
  45. 7.8.2 Bluebird Bio Business Overview
  46. 7.8.3 Bluebird Bio Hemoglobinopathy Testing Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bluebird Bio Hemoglobinopathy Testing Services Product Portfolio
  48. 7.8.5 Bluebird Bio Recent Developments
  49. 7.9 Acceleron Pharma
  50. 7.9.1 Acceleron Pharma Company Information
  51. 7.9.2 Acceleron Pharma Business Overview
  52. 7.9.3 Acceleron Pharma Hemoglobinopathy Testing Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Acceleron Pharma Hemoglobinopathy Testing Services Product Portfolio
  54. 7.9.5 Acceleron Pharma Recent Developments
8 North America
  1. 8.1 North America Hemoglobinopathy Testing Services Revenue (2021-2032)
  2. 8.2 North America Hemoglobinopathy Testing Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Hemoglobinopathy Testing Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Hemoglobinopathy Testing Services Revenue by Type (2027-2032)
  5. 8.3 North America Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Hemoglobinopathy Testing Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Hemoglobinopathy Testing Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Hemoglobinopathy Testing Services Revenue by Application (2027-2032)
  9. 8.5 North America Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Hemoglobinopathy Testing Services Revenue by Country
  11. 8.6.1 North America Hemoglobinopathy Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Hemoglobinopathy Testing Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Hemoglobinopathy Testing Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Hemoglobinopathy Testing Services Revenue (2021-2032)
  2. 9.2 Europe Hemoglobinopathy Testing Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Hemoglobinopathy Testing Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Hemoglobinopathy Testing Services Revenue by Type (2027-2032)
  5. 9.3 Europe Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Hemoglobinopathy Testing Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Hemoglobinopathy Testing Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Hemoglobinopathy Testing Services Revenue by Application (2027-2032)
  9. 9.5 Europe Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Hemoglobinopathy Testing Services Revenue by Country
  11. 9.6.1 Europe Hemoglobinopathy Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Hemoglobinopathy Testing Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Hemoglobinopathy Testing Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Hemoglobinopathy Testing Services Revenue (2021-2032)
  2. 10.2 China Hemoglobinopathy Testing Services Revenue by Type (2021-2032)
  3. 10.2.1 China Hemoglobinopathy Testing Services Revenue by Type (2021-2026)
  4. 10.2.2 China Hemoglobinopathy Testing Services Revenue by Type (2027-2032)
  5. 10.3 China Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032)
  6. 10.4 China Hemoglobinopathy Testing Services Revenue by Application (2021-2032)
  7. 10.4.1 China Hemoglobinopathy Testing Services Revenue by Application (2021-2026)
  8. 10.4.2 China Hemoglobinopathy Testing Services Revenue by Application (2027-2032)
  9. 10.5 China Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Hemoglobinopathy Testing Services Revenue (2021-2032)
  2. 11.2 Asia Hemoglobinopathy Testing Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Hemoglobinopathy Testing Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Hemoglobinopathy Testing Services Revenue by Type (2027-2032)
  5. 11.3 Asia Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Hemoglobinopathy Testing Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Hemoglobinopathy Testing Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Hemoglobinopathy Testing Services Revenue by Application (2027-2032)
  9. 11.5 Asia Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Hemoglobinopathy Testing Services Revenue by Country
  11. 11.6.1 Asia Hemoglobinopathy Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Hemoglobinopathy Testing Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Hemoglobinopathy Testing Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Hemoglobinopathy Testing Services Revenue (2021-2032)
  2. 12.2 SAMEA Hemoglobinopathy Testing Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Hemoglobinopathy Testing Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Hemoglobinopathy Testing Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Hemoglobinopathy Testing Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Hemoglobinopathy Testing Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Hemoglobinopathy Testing Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Hemoglobinopathy Testing Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Hemoglobinopathy Testing Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Hemoglobinopathy Testing Services Revenue by Country
  11. 12.6.1 SAMEA Hemoglobinopathy Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Hemoglobinopathy Testing Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Hemoglobinopathy Testing Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst